Functional Dyspepsia: Diagnostic and Therapeutic Approaches
- PMID: 32691294
- DOI: 10.1007/s40265-020-01362-4
Functional Dyspepsia: Diagnostic and Therapeutic Approaches
Abstract
Functional dyspepsia is a common functional gastrointestinal (GI) disorder of gastroduodenal origin, diagnosed clinically in the presence of prototypical symptoms of epigastric pain and meal-related symptoms, and without structural explanation. The most recent diagnostic criteria provide for two functional dyspepsia subtypes, epigastric pain syndrome (EPS) and post-prandial distress syndrome (PDS) based on the predominant symptom pattern. The evaluation of dyspepsia should keep laboratory, imaging, and invasive testing to a minimum, as extensive or repetitive investigations are of rather low diagnostic yield in the absence of localizing symptoms or alarm features. Factors with etiopathologic relationships to functional dyspepsia include micro-inflammation, GI infections, abnormalities of gastroduodenal motility, visceral hypersensitivity, disturbances along the brain-gut axis, and psychological factors; all of these causative mechanisms have potential to partially explain symptoms in some functional dyspepsia patients, thus providing a rationale for the efficacy of a diversity of therapeutic approaches to functional dyspepsia. Management of dyspepsia symptoms relies upon both pharmacologic treatments and non-pharmacologic approaches, including psychological and complementary interventions. The evidence in support of established functional dyspepsia therapies is reviewed, and forms the basis for an effective functional dyspepsia treatment strategy emphasizing the patient's current symptom severity, pattern, and impact on the function and quality of life of the individual.
Similar articles
-
Rome III functional dyspepsia subdivision in PDS and EPS: recognizing postprandial symptoms reduces overlap.Neurogastroenterol Motil. 2015 Aug;27(8):1069-74. doi: 10.1111/nmo.12585. Neurogastroenterol Motil. 2015. PMID: 26220647
-
Fasting and postprandial gastric sensorimotor activity in functional dyspepsia: postprandial distress vs. epigastric pain syndrome.Am J Gastroenterol. 2014 Oct;109(10):1631-9. doi: 10.1038/ajg.2014.231. Epub 2014 Sep 9. Am J Gastroenterol. 2014. PMID: 25199472
-
Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification.Am J Gastroenterol. 2013 May;108(5):767-74. doi: 10.1038/ajg.2013.89. Epub 2013 Apr 9. Am J Gastroenterol. 2013. PMID: 23567354
-
Postprandial distress syndrome: stratification and management.Expert Rev Gastroenterol Hepatol. 2019 Jan;13(1):37-46. doi: 10.1080/17474124.2019.1543586. Epub 2018 Nov 8. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791841 Review.
-
[Current issues in functional dyspepsia].Korean J Gastroenterol. 2014 Sep 25;64(3):133-41. doi: 10.4166/kjg.2014.64.3.133. Korean J Gastroenterol. 2014. PMID: 25252861 Review. Korean.
Cited by
-
Network analysis and experimental validation to investigate chenpi against functional dyspepsia through TLR4/MyD88 by regulating the gut microbial structure.Front Pharmacol. 2025 Feb 13;16:1495799. doi: 10.3389/fphar.2025.1495799. eCollection 2025. Front Pharmacol. 2025. PMID: 40017602 Free PMC article.
-
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial.Nat Commun. 2024 Jan 3;15(1):227. doi: 10.1038/s41467-023-44292-x. Nat Commun. 2024. PMID: 38172093 Free PMC article. Clinical Trial.
-
Systematic Survey of the Alteration of the Faecal Microbiota in Rats With Gastrointestinal Disorder and Modulation by Multicomponent Drugs.Front Pharmacol. 2021 Nov 2;12:670335. doi: 10.3389/fphar.2021.670335. eCollection 2021. Front Pharmacol. 2021. PMID: 34803663 Free PMC article. Review.
-
Clinical study status of diabetic gastrointestinal diseases.Front Endocrinol (Lausanne). 2025 Apr 9;16:1568552. doi: 10.3389/fendo.2025.1568552. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40270718 Free PMC article.
-
The mediating effect of circulating inflammatory proteins on the relationship between gut microbiota and FD: a bidirectional Mendelian randomization study.Sci Rep. 2024 Oct 11;14(1):23785. doi: 10.1038/s41598-024-74717-6. Sci Rep. 2024. PMID: 39390038 Free PMC article.
References
-
- Functional Gastrointestinal Disorders. Disorders of gut–brain interaction. Raleigh: Rome Foundation; 2016.
-
- Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal disorders. Gastroenterology. 2016;150:1380–92. - PubMed
-
- Talley NJ, Ford AC. Functional dyspepsia. N Engl J Med. 2015;373:1853–63. - PubMed
-
- Ford AC, Marwaha A, Sood R, et al. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64:1049–57. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous